On the scientific and ethical issues of fetal somatic gene therapy

[1]  J. Hobbins,et al.  In utero gene delivery by intraamniotic injection of a retroviral vector producer cell line in a nonhuman primate model. , 2001, Human gene therapy.

[2]  Jun Yu Li,et al.  Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  J. Delcarpio,et al.  Gene transfer into the fetal primate: evidence for the secretion of transgene product. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  A. Douar,et al.  Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B , 1999, The journal of gene medicine.

[5]  C. Rodeck,et al.  Successful expression of β-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein , 1999, Gene Therapy.

[6]  Haig H. Kazazian,et al.  An estimated frequency of endogenous insertional mutations in humans , 1999, Nature Genetics.

[7]  W. Anderson,et al.  In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. , 1998, Human gene therapy.

[8]  A. Harris,et al.  Towards an ovine model of cystic fibrosis. , 1997, Human molecular genetics.

[9]  A. Douar,et al.  Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus , 1997, Gene Therapy.

[10]  V. Sandig,et al.  Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection. , 1996, Gene therapy.

[11]  J. Fletcher,et al.  Human fetal gene therapy: moral and ethical questions. , 1996, Human gene therapy.

[12]  W. Colledge,et al.  The challenge of fetal gene therapy , 1995, Nature Medicine.

[13]  W. Rascher,et al.  Sustained delivery of therapeutic concentrations of human clotting factor IX – a comparison of adenoviral and AAV vectors administered in utero , 2002, The journal of gene medicine.

[14]  C. Rodeck,et al.  Fetal somatic gene therapy--a preventive approach to the treatment of genetic disease: the case for. , 2001, Ernst Schering Research Foundation workshop.